Merck KGaA agreed to buy SpringWorks Therapeutics Inc., a maker of medicines for cancer and rare diseases, to boost its ...

Merck KGaA acquires SpringWorks Therapeutics for $3.9B to enhance its cancer drug portfolio, boosting revenue growth and ...

After months of discussion, Germany’s Merck KGaA said Monday it would buy SpringWorks Therapeutics for $47 a share in cash, a ...

German healthcare and materials group Merck KGaA has struck a deal, it said on Monday, to acquire U.S. biotech company ...

Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, Connecticut-based commercial-stage biopharmaceutical ...

Conservationist Peter Seligmann; writer, actor and director Ramy Youssef and acclaimed visual artist Mickalene Thomas will ...

(Reuters) -Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, the Wall Street Journal ...

Soon after graduation this spring, Neha Bhat will start a job as a Global Marketing New Analyst for Goldman Sachs, a position ...

Eli Lilly said on Wednesday it had sued four compounders for selling unapproved products containing tirzepatide, after a U.S.

The Health Solutions West detox center, formerly known as Mind Springs is seen on April 22. Health Solutions Chief Executive ...